Related Experiment Video
Updated: May 16, 2026

Ginger Moxibustion, A Non-pharmacological Treatment, for Diarrhea in Patients with Chronic Obstructive Pulmonary Disease
Published on: December 27, 2024
Review article: the management of acute gastroenteritis in children
M Pieścik-Lech1, R Shamir, A Guarino
1Department of Paediatrics, The Medical University of Warsaw, Dzialdowska 1, Warsaw, Poland.
Insights
Updated guidelines for managing acute gastroenteritis (AGE) in children are needed. New evidence supports rapid rehydration, ondansetron for vomiting, and probiotics, but questions remain about safety and efficacy in Europe.
Area of Science:
- Pediatric Gastroenterology
- Infectious Diseases
- Evidence-Based Medicine
Background:
- The European Society for Paediatric Gastroenterology, Hepatology and Nutrition (ESPGHAN) and the European Society of Paediatric Infectious Disease (ESPID) established guidelines for childhood acute gastroenteritis (AGE) in 2008.
- This review focuses on advancements and new evidence published since the 2008 guidelines.
Purpose of the Study:
- To summarize recent research and data published after the 2008 ESPGHAN/ESPID guidelines.
- To identify areas requiring updates in current pediatric gastroenteritis management recommendations.
Main Methods:
- A systematic literature search was conducted using MEDLINE and The Cochrane Library.
- The search focused on randomized controlled trials (RCTs) and meta-analyses published after 2008.
Main Results:
- Oral rehydration solutions (ORS) show promise for improved taste and efficacy.
- Rapid rehydration (4-hour) is effective, alongside standard nasogastric methods. Intravenous rehydration strategies are being explored.
- Ondansetron effectively reduces vomiting, though pediatric safety requires further evaluation. Zinc supplementation is not beneficial in Europe. Smectite, racecadotril, and probiotics (Lactobacillus GG, S. boulardii) are effective adjunctive therapies.
Conclusions:
- The existing ESPGHAN/ESPID recommendations for managing acute gastroenteritis in children require updating.
- Further research is needed to clarify safety and efficacy of certain interventions, particularly in the European context.
Background:
In 2008, the European Society for Paediatric Gastroenterology, Hepatology and Nutrition (ESPGHAN) and the European Society of Paediatric Infectious Disease (ESPID) developed evidence-based guidelines for the management of acute gastroenteritis (AGE) in children in Europe.
Aim:
To summarise data published subsequently to the ESPGHAN/ESPID guidelines.
Methods:
MEDLINE and The Cochrane Library were searched in August 2012 for randomised controlled trials (RCTs) or their meta-analyses published after 2008.
Results:
Efforts to improve the taste and/or efficacy of oral rehydration solution (ORS) continue, and some interventions are promising. While standard (over 24 h) nasogastric rehydration is still being used, new evidence confirms that rapid (over 4 h) rehydration is also effective. For intravenous rehydration, new evidence is available regarding rapid or ultrarapid and large-volume vs. standard-volume rehydration; as the new evidence is not consistent, until more data are available, the administration of 20 mL/kg seems appropriate. Convincing evidence has accumulated showing that ondansetron reduces the risk for vomiting; however, a clearance on safety in children is needed. New evidence has reconfirmed that in Europe, where zinc deficiency is rare, there is no benefit from the use of zinc. New data, although mainly from outside of Europe, have reconfirmed that either smectite or racecadotril is an effective adjunctive therapy to oral rehydration. There is a clear effect of using certain probiotics, such as Lactobacillus GG or S. boulardii.
Conclusions:
The update of current ESPGHAN/ESPID recommendations is warranted.
Related Concept Videos
Acute Pancreatitis II: Clinical Manifestations and Management
Gastritis III: Clinical Manifestations and Management
Clinical manifestations of acute gastritis
The patient with acute gastritis may have a rapid onset of symptoms, such as epigastric pain or discomfort, dyspepsia, anorexia, hiccups, or nausea and vomiting, which can last from a few hours to a few days. Erosive or hemorrhagic gastritis may cause bleeding, which may manifest as blood in vomit or as...
Pharmacokinetics in Pediatric Patients: Overview and Drug Absorption
Acute Pyelonephritis II: Diagnostic Studies and Management
Bacterial Gastroenteritis
Drugs Affecting GI Tract Motility: Antimicrobials as Antidiarrheal Agents